Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2022 / 01:40PM GMT
Release Date Price: €55.26
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

My name is Jeff Johnson. I'm the senior medical technology analyst at Baird. Our next presentation this morning is from Tandem Diabetes, a leader in the $3.5 billion global insulin pump market. With us today from Tandem, we're happy to have President and Chief Executive Officer, John Sheridan; as well as Chief Financial Officer, Leigh Vosseller.

John, I'll turn it over to you if you have a few prepared remarks, and then we'll just go into Q&A.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Welcome, everybody. It's good to see you, Jeff. I think I wanted to start off by just clarifying some of the things that we said on the 2Q call. We indicated that we had experienced pressure in June and July from a variety of factors. And as we exit the month of August, what we have seen is we've seen a positive shift. And we think it's the beginning of the momentum build that lines up with the guidance that we gave during the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot